Research Peptide Comparison
CJC-1295 without DAC 5mg and SLU-PP-332 5mg are both Research Peptides research peptides available from Neovia Peptides. This comparison highlights the key differences in specifications, pricing, and availability to help inform your research decisions.
CJC-1295 without DAC, also referenced in the literature as Modified GRF 1-29, is a 30-amino-acid growth hormone-releasing hormone (GHRH) analog stabilised against enzymatic degradation but without the albumin-binding DAC moiety. Its short half-life produces a pulsatile GH-release profile that more closely approximates endogenous somatotropic signalling, making it a frequent reference compound in GHRH receptor and pituitary-response studies.
Compared to SLU-PP-332 5mg, CJC-1295 without DAC 5mg is priced at £27.99 with 99%+ verified purity. Its CAS registry number is 863288-34-0. It has a molecular weight of 3367.97 g/mol.
CJC-1295 without DAC 5mg is available in single size and ships with a full Certificate of Analysis from Janoshik Analytical. At £12.00 less than SLU-PP-332 5mg, it is the more affordable option in this comparison.
SLU-PP-332 is a small-molecule selective pan-agonist of the oestrogen-related receptors (ERRα, ERRβ and ERRγ), orphan nuclear receptors that regulate mitochondrial biogenesis, oxidative metabolism and skeletal muscle endurance programmes. By engaging all three ERR subtypes it has emerged as a leading exercise-mimetic research tool for interrogating metabolic adaptation and oxidative capacity.
Compared to CJC-1295 without DAC 5mg, SLU-PP-332 5mg is priced at £39.99 with 99%+ verified purity. It has a molecular weight of 438.52 g/mol.
SLU-PP-332 5mg is available in single size and ships with a full Certificate of Analysis from Janoshik Analytical. It is priced £12.00 higher than CJC-1295 without DAC 5mg.
All products sold by Neovia Peptides are strictly for in-vitro research and laboratory use only. Not intended for human or veterinary use, food additives, drugs, or cosmetics. By purchasing from this website, you agree that you understand and accept these terms.
